15 September 2020 The Medical Device Partnering Program today launches the first dedicated online Capability Directory for the medical device sector, to boost innovation and development of cutting-edge medical devices and technologies in Australia. Funded by MTPConnect, the…
15 September 2020 Planet Innovation and Lumos Diagnostics have won two awards at the 2020 Good Design Awards, including a Good Design Award Gold accolade for Lumos’s Leelu Reader. The annual Good Design Awards is Australia’s oldest and most…
15 September 2020 Release date 14 September 2020 Cynata Therapeutics Limited, a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that a paper describing the Phase 1 clinical trial of CYP-001 in patients with graft…
15 September 2020 New data generated at Scripps Research Institute in the US shows that Starpharma’s antiviral nasal spray active (SPL7013) is virucidal, inactivating more than 99.9% of SARS-CoV-2, the virus that causes COVID-19 Potent antiviral activity of…
15 September 2020 Release date 14 September 2020 A world-first device to restore vision to the blind is being prepared for human clinical trials in Melbourne. Additional funding can help researchers establish an implantable device manufacturing facility to…
15 September 2020 Release date 11 September 2020 Australia’s largest Phase 1 clinical trials specialist, Nucleus Network, has this week started the first human trials of a potential COVID-19 treatment developed by Singlomics (Beijing DanXu) Biopharmaceuticals and licensed…
15 September 2020 Release date 11 September 2020 The University of Melbourne has brought together industry partners and researchers for the development of an Australian-first; locally manufactured 3D printed nasal swab for coronavirus (COVID-19) testing. 3DMEDiTECH, a partner…
14 September 2020 In what has been a steadily positive research progression so far, Melbourne-based clinical-stage biopharmaceutical company Dimerix has reported a continuation of strong clinical trial results for its drug candidate DMX-200, which is aimed at a…
14 September 2020 Release date 10 September 2020 PRODIGY Study Provides First Validated Risk Prediction Tool to Guide Continuous Monitoring for Opioid-Induced Respiratory Depression (OIRD) OIRD Occurred in 46% of Patients Studied Patients with Respiratory Depression Are 37%…
13 September 2020 Gilead Adds TrodelvyTM, First-in-Class Antibody-Drug Conjugate Approved to Treat Triple-Negative Breast Cancer, With Promise in Other Forms of Breast Cancer and Additional Solid Tumors Acquisition Transforms Gilead’s Portfolio with First-in-Class Commercial Product with Significant Revenue and…
14 September 2020 Release date 12 September 2020 CT:IQ together with Medicines Australia (MA), Medical Technology Association of Australia (MTAA) and AusBiotech have released a joint position statement confirming that eSignatures can be used to execute clinical trial…
14 September 2020 Silicon Valley start-up Levitas Bio has launched the world’s first label-free cell separation platform, the LeviCell™. The benchtop device uses revolutionary magnetic levitation technology developed at Stanford University to sort cell populations, without modifying the cells with…